Disparity in Market Prices for Hepatitis C Virus Direct-Acting Drugs
MetadataShow full item record
- Hepatitis C: how has France limited the expenses related to new treatments?
- Authors: Mouterde AL, Bocquet F, Fusier I, Paubel P
- Issue date: 2016 Dec
- New hepatitis C therapies: the toolbox, strategies, and challenges.
- Authors: Pawlotsky JM
- Issue date: 2014 May
- [Prescription of new HCV-drugs - what has to be considered judicially].
- Authors: Mauss S
- Issue date: 2015 Jan
- Management of hepatitis B virus infection in the underprivileged world.
- Authors: Almasio PL, Craxì A
- Issue date: 2011 Jul
- Screening urged for hepatitis C but drug costs are prohibitive.
- Authors: Fralick M
- Issue date: 2014 Mar 18